Melanoma and other malignant cells often exhibit impaired antiviral defenses and those expressing high levels of ICAM-1 can be efficiently infected and lysed by the virus, resulting in tumor destruction accompanied by innate and adaptive immune responses [12,18,21,22]. The gene discussed is ICAM1; the disease is melanoma.